Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
orcinoside
- Development stage
- Phase 2
- Lead developer
- Kunming Institute of Zoology
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Orcinoside is a natural product-derived small molecule developed as a novel antidepressant. It has been investigated primarily for the treatment of major depressive disorder (MDD). Orcinoside acts on the central nervous system and has demonstrated efficacy in clinical trials for depression. The drug was initially developed by the Kunming Institute of Zoology and is classified as a Class 1 natural antidepressant in China. Its mechanism of action is not fully elucidated but it is believed to modulate neurotransmitter systems relevant to mood regulation. Clinical studies have evaluated its safety, tolerability, pharmacokinetics, and dose-response relationship in both healthy volunteers and patients with depression[1][3][10].
- Brand names
- 奥生乐赛特Osanolate
- Other names
- orcinosideOsanolate奥生乐赛特
02
Targets
AMPAR (AMPA receptor)NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on orcinoside.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on orcinoside.